Last edition
News about "IPC sounds safety alert against hepatitis C drug s"
IPC sounds safety alert against hepatitis C drug sofosbuvir
The Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) has flagged a drug safety alert revealing that sofosbuvir which is used in combination with other medicinal products for the treatment of chronic hepatitis C in adults is associated with Stevens-Johnson Syndrome
IPC Sounds Safety Alert Against Hepatitis C Drug S | 04/09/2021 | By Darshana | 260
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy